FDA Approved: BLISOVI FE 1.5/30 — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' BLISOVI FE 1.5/30 through a supplemental approval, adding a 1.5 mg norethindrone/30 mcg ethinyl estradiol dose formulation. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• BLISOVI FE 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for BLISOVI FE 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)